Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Boston Scientific (BSX) shares
Learn how to easily invest in Boston Scientific shares.
Boston Scientific Corporation (BSX) is a leading medical devices business based in the US. It opened the day at USD$40.38 after a previous close of USD$40.43. During the day the price has varied from a low of USD$40.125 to a high of USD$41.48. The latest price was USD$40.86 (25 minute delay). Boston Scientific is listed on the NYSE and employs 41,000 staff. All prices are listed in US Dollars.
How to buy shares in Boston Scientific
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BSX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Boston Scientific shares at a glance
|52-week range||$37.96 - $47.50|
|50-day moving average||$42.86|
|200-day moving average||$43.00|
|Wall St. target price||$50.38|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.53|
Boston Scientific stock price (NYSE:BSX)Use our graph to track the performance of BSX stocks over time.
Boston Scientific price performance over time
|1 week (2022-05-18)||1.57%|
|1 month (2022-04-22)||N/A|
|3 months (2022-02-23)||-6.52%|
|6 months (2021-11-26)||5.94%|
|1 year (2021-05-26)||-2.32%|
|2 years (2020-05-26)||12.90%|
|3 years (2019-05-24)||6.21%|
|5 years (2017-05-26)||49.56%|
Is Boston Scientific under- or over-valued?
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Boston Scientific's P/E ratio
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Boston Scientific shares trade at around 74x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Boston Scientific's PEG ratio
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3897. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Boston Scientific's EBITDA
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
Boston Scientific financials
|Revenue TTM||$12.2 billion|
|Operating margin TTM||17.47%|
|Gross profit TTM||$8.2 billion|
|Return on assets TTM||4.2%|
|Return on equity TTM||4.99%|
|Market capitalisation||$56.1 billion|
TTM: trailing 12 months
Boston Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Boston Scientific's total ESG risk score
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Boston Scientific's environmental score
Environmental score: 1.51/100
Boston Scientific's social score
Social score: 12.87/100
Boston Scientific's governance score
Governance score: 7.87/100
Boston Scientific's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Boston Scientific share dividends
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Have Boston Scientific's shares ever split?
Boston Scientific's shares were split on a 2:1 basis on 5 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Boston Scientific share price volatility
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $37.96 up to $47.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8147. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Frequently asked questions
Boston Scientific in the news
Boston Scientific Could Be Wicked Good in This Kind of Market
Belo Sun Receives Interim Suspension Order Related to the Construction and Environmental Licenses for the Volta Grande Project
Former White House press secretary Jen Psaki will join MSNBC this fall
More guides on Finder
BlackBull Markets share trading review
Your detailed review of share trading with BlackBull Markets, including brokerage fees, safety, pros and cons, and more.
Jarden Direct Share Trading review
Thinking of trading shares with Jarden Direct? Check out our review of Jarden Direct fees, safety, and pros and cons first.
Tiger Brokers share trading review
Your detailed review of online share trading with Tiger Brokers, including fees, markets, safety, pros and cons, and how to sign up.
Investor influx: 1 in 4 Kiwis are using share trading platforms
A growing number of Kiwis are investing in the stock market via an app or online platform, according to research by Finder.
How to buy Valkyrie Bitcoin Strategy ETF (BTF) from New Zealand
The second Bitcoin future ETF is set to go live Oct. 22. Here’s how to invest if you’re in New Zealand.
How to buy VanEck Bitcoin Strategy ETF units from New Zealand
Steps to owning and managing VanEck Bitcoin Strategy ETF units.
How to buy BITO ETF (BITO) shares
Steps to owning and managing ProShares Bitcoin Strategy ETF, with 24-hour and historical pricing before you buy.
Best performing New Zealand shares
We present the 10 best performing shares on the NZX over the last 3 months and show you how you can invest in them.
How to invest in fractional shares
Fractional shares are fractions of company shares. Sometimes they’re made by brokers to allow those with limited funds to get access to stocks.
Day trading : What it is and how it works
How day trading works, what to watch out for and how to pick a broker.
Ask an Expert